OssDsign Valuation Multiples

OssDsign Overview

About OssDsign

OssDsign AB is a developer and international provider of next-generation orthobiologics products. The company's product OssDsign Catalyst is a bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries. Geographically the company generates revenue from the USA, Germany, Sweden, the UK, the Rest of Europe, and the Rest of world. The company generates the majority of its revenue from the USA.

Founded

2011

HQ

Employees

27

Website

ossdsign.com

Sectors

Medical DevicesHealthTechDeepTech

Financials (LTM)

Revenue: $21M

EBITDA: ($4M)

EV

$29M

Valuation Multiples

Multiples.vc

Start free trial

OssDsign Financials

OssDsign reported last 12-month revenue of $21M and negative EBITDA of ($4M).

In the same LTM period, OssDsign generated $20M in gross profit, ($4M) in EBITDA losses, and had net loss of ($5M).

OssDsign P&L

In the most recent fiscal year, OssDsign reported revenue of $20M and EBITDA of ($4M).

OssDsign expects next 12-month revenue of XXX and NTM EBITDA of XXX

OssDsign Stock Performance

OssDsign has current market cap of $49M, and enterprise value of $29M.

OssDsign's stock price is $0.45.

OssDsign Valuation Multiples

OssDsign trades at 1.4x EV/Revenue multiple, and (7.6x) EV/EBITDA.

OssDsign Financial Valuation Multiples

As of April 20, 2026, OssDsign has market cap of $49M and EV of $29M.

Equity research analysts estimate OssDsign's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

OssDsign has a P/E ratio of (9.4x).

OssDsign Margins & Growth Rates

OssDsign's revenue in the last 12 month grew by 22%.

OssDsign's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.9M for the same period.

OssDsign's rule of 40 is 4% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

OssDsign's rule of X is 32% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

OssDsign Public Comps

See public comps and valuation multiples for other Medical Devices comps.

OssDsign M&A Activity

OssDsign acquired XXX companies to date.

Last acquisition by OssDsign was on XXXXXXXX, XXXXX. OssDsign acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

OssDsign Investment Activity

OssDsign invested in XXX companies to date.

OssDsign made its latest investment on XXXXXXXX, XXXXX. OssDsign invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).